Renal transplantation in anti-neutrophil cytoplasmic antibody vasculitis

References

• Moiseev S, Novikov P, Jayne D, et al. End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant. 2017 Feb 1;32(2):248–253.
   PubMed Web of Science ®Google Scholar
• Tan JA, Dehghan N, Chen W, et al. Mortality in ANCA-associated vasculitis: a meta-analysis of observational studies. Ann Rheum Dis. 2017 Sep;76(9):1566–1574.
   PubMed Web of Science ®Google Scholar
• Novikov PI, Moiseev SV, Kuznetsova EI, et al. Changing patterns of clinical severity and risk of mortality in granulomatosis with polyangiitis over four decades: the Russian experience. Rheumatol Int. 2015 May;35(5):891–898.
   PubMed Web of Science ®Google Scholar
• Moiseev SV, Novikov PI, Smitienko I. ANCA-associated vasculitis: mission incomplete. Ann Rheum Dis. 2017 Jun 12;77:1–3.
   Google Scholar
• de Joode AAE, Sanders JSF, Stegeman CA. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013 Oct;8(10):1709–1717.
   PubMed Web of Science ®Google Scholar
• Flossmann O, Berden A, de Groot K, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis. 2011 Mar;70(3):488–494.
   PubMed Web of Science ®Google Scholar
• Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999 Dec 2;341(23):1725–1730.
   PubMed Web of Science ®Google Scholar
• Schnuelle P, Lorenz D, Trede M, et al. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol. 1998 Nov;9(11):2135–2141.
   PubMed Web of Science ®Google Scholar
• Hruskova Z, Stel VS, Jayne D, et al. Characteristics and outcomes of granulomatosis with polyangiitis (Wegener) and microscopic polyangiitis requiring renal replacement therapy: results from the European Renal Association-European Dialysis and Transplant Association Registry. Am J Kidney Dis. 2015 Oct;66(4):613–620.
   PubMed Web of Science ®Google Scholar
• Lyons GW, Lindsay WG. Renal transplantation in a patient with Wegener’s granulomatosis. Am J Surg. 1972 Jul;124(1):104–107.
   PubMed Web of Science ®Google Scholar
• Cecka JM, Terasaki PI. The UNOS Scientific Renal Transplant Registry. United Network for Organ Sharing. Clin Transpl. 1995;1–18.
   PubMedGoogle Scholar
• Briggs JD, Jones E. Renal transplantation for uncommon diseases. Scientific advisory board of the ERA-EDTA registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant. 1999;14(3):570–575.
   PubMedGoogle Scholar
• Opelz G, Döhler B, Ruhenstroth A, et al. The collaborative transplant study registry. Transplant Rev (Orlando). 2013 Apr;27(2):43–45.
   PubMedGoogle Scholar
• Little MA, Hassan B, Jacques S, et al. Renal transplantation in systemic vasculitis: when is it safe? Nephrol Dial Transplant. 2009 Oct;24(10):3219–3225.
   PubMed Web of Science ®Google Scholar
• Geetha D, Eirin A, True K, et al. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience. Transplantation [Internet]. 2011 Jun 27 [cited 2017 Dec 4];91(12):1370–1375.
   PubMed Web of Science ®Google Scholar
• O’Shaughnessy MM, Liu S, Montez-Rath ME, et al. Kidney transplantation outcomes across GN subtypes in the United States. J Am Soc Nephrol. 2017 Feb;28(2):632–644.
   PubMed Web of Science ®Google Scholar
• Segelmark M. L23. Renal transplantation in ANCA-associated vasculitis. Presse Med. 2013 Apr;42(4 Pt 2):568–571.
   PubMedGoogle Scholar
• Kidney disease: improving global outcomes (KDIGO) glomerulonephritis [Internet]. Working group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2:139–274.
   Web of Science ®Google Scholar
• Knoll G, Cockfield S, Blydt-Hansen T, et al. Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation. CMAJ. 2005 Nov 8;173(10):1181–1184.
   PubMed Web of Science ®Google Scholar
• Nachman PH, Segelmark M, Westman K, et al. Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis. Kidney Int. 1999 Oct;56(4):1544–1550.
   PubMed Web of Science ®Google Scholar
• Marco H, Mirapeix E, Arcos E, et al. Long-term outcome of antineutrophil cytoplasmic antibody-associated small vessel vasculitis after renal transplantation. Clin Transplant [Internet]. 2013 May–Jun;27(3):338–347.
   PubMed Web of Science ®Google Scholar
• Geetha D, Lee SM, Shah S, et al. Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis. J Nephrol. 2017 Feb;30(1):147–153.
   PubMed Web of Science ®Google Scholar
• Hogan SL, Falk RJ, Chin H, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005 Nov 1;143(9):621–631.
   PubMed Web of Science ®Google Scholar
• Cao Y, Tian Z, Li W, et al. Predictors of treatment resistance and relapse in Chinese patients with antineutrophil cytoplasmic antibody-associated disease. J Rheumatol. 2014 May;41(5):916–922.
   PubMed Web of Science ®Google Scholar
• Weidanz F, Day CJ, Hewins P, et al. Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis. 2007 Jul;50(1):36–46.
   PubMed Web of Science ®Google Scholar
• Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol. 1998 Jul;9(7):1258–1263.
   PubMed Web of Science ®Google Scholar
• Lionaki S, Hogan SL, Jennette CE, et al. The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int. 2009 Sep;76(6):644–651.
   PubMed Web of Science ®Google Scholar
• Steinman TI, Jaffe BF, Monaco AP, et al. Recurrence of Wegener’s granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide. Am J Med. 1980 Mar;68(3):458–460.
   PubMed Web of Science ®Google Scholar
• Hruskova Z, Geetha D, Tesar V. Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant. 2015 Apr;30(Suppl 1):159.
   Google Scholar
• Curtis JJ, Diethelm AG, Herrera GA, et al. Recurrence of Wegener’s granulomatosis in a cadaver renal allograft. Transplantation. 1983 Oct;36(4):452–454.
   PubMed Web of Science ®Google Scholar
• Rich LM, Piering WF. Ureteral stenosis due to recurrent Wegener’s granulomatosis after kidney transplantation. J Am Soc Nephrol. 1994 Feb;4(8):1516–1521.
   PubMed Web of Science ®Google Scholar
• Reaich D, Cooper N, Main J. Rapid catastrophic onset of Wegener’s granulomatosis in a renal transplant. Nephron. 1994;67(3):354–357.
   PubMed Web of Science ®Google Scholar
• Göçeroğlu A, Rahmattulla C, Berden AE, et al. Dutch transplantation in vasculitis (DUTRAVAS)-study: update on the outcome of renal transplantation in ANCA-associated vasculitis (AAV) patients in the Netherlands. La Presse Médicale. 2013 Mar 26;42:658–659. Available from: /data/revues/07554982/v42i4sP2/S0755498213001231/
   Google Scholar
• Briganti EM, Russ GR, McNeil JJ, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med. 2002 Jul 11;347(2):103–109.
   PubMed Web of Science ®Google Scholar
• Göçeroğlu A, Rahmattulla C, Berden AE, et al. The Dutch Transplantation in Vasculitis (DUTRAVAS) Study: outcome of renal transplantation in antineutrophil cytoplasmic antibody-associated glomerulonephritis. Transplantation. 2016 Apr 1;100(4):916–924.
   PubMed Web of Science ®Google Scholar
• Deegens JKJ, Artz MA, Hoitsma AJ, et al. Outcome of renal transplantation in patients with pauci-immune small vessel vasculitis or anti-GBM disease. Clin Nephrol. 2003 Jan;59(1):1–9.
   PubMed Web of Science ®Google Scholar
• Tang W, Bose B, McDonald SP, et al. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand. Clin J Am Soc Nephrol. 2013 May;8(5):773–780.
   PubMed Web of Science ®Google Scholar
• Schmitt WH, Opelz G, van DerWoude FJ. Renal transplantation (RTx) is safe and successful in Wegener’s granulomatosis (WG): data from the collaborative transplant study. J Am Soc Nephrol. 2002;13:564A–565A.
   Web of Science ®Google Scholar
• Gera M, Griffin MD, Specks U, et al. Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosuppression. Kidney Int. 2007 Jun;71(12):1296–1301.
   PubMed Web of Science ®Google Scholar
• Geetha D, Haas M, Kraus ES, et al. Renal transplant in Wegener’s granulomatosis compared to microscopic polyangiitis. J Rheumatol. 2010 Aug 1;37(8):1705–1708.
   PubMed Web of Science ®Google Scholar
• Walsh M, Merkel PA, Mahr A, et al. Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis. Arthritis Care Res (Hoboken). 2010 Aug;62(8):1166–1173.
   PubMed Web of Science ®Google Scholar
• Specks U, Merkel PA, Seo P, et al. Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med. 2013 Aug 1;369(5):417–427.
   PubMed Web of Science ®Google Scholar
• Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010 Jul 15;363(3):221–232.
   PubMed Web of Science ®Google Scholar
• Marinaki S, Skalioti C, Boletis JN. B cell depletion: rituximab in glomerular disease and transplantation. Nephron Extra. 2013 Jan;3(1):125–130.
   PubMedGoogle Scholar
• Hermle T, Goestemeyer A, Sweny P, et al. Successful therapeutic use of rituximab in refractory Wegener’s granulomatosis after renal transplantation. Clin Nephrol. 2007 Nov;68(5):322–326.
   PubMed Web of Science ®Google Scholar
• Geetha D, Seo P, Specks U, et al. Successful induction of remission with rituximab for relapse of ANCA-associated vasculitis post-kidney transplant: report of two cases. Am J Transplant. 2007 Dec;7(12):2821–2825.
   PubMed Web of Science ®Google Scholar
• Murakami C, Manoharan P, Carter-Monroe N, et al. Rituximab for remission induction in recurrent ANCA-associated glomerulonephritis postkidney transplant. Transpl Int. 2013 Dec;26(12):1225–1231.
   PubMed Web of Science ®Google Scholar